Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia

Movement Disorders(2024)10.1002/mds.29960Source: DataRank Database

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia is a research paper published in Movement Disorders (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: hybridTopics (48)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (37)

Sara Bandrés‐Ciga ORCID,Bart Ferwerda ORCID,Maria Teresa Periñan Tocino,Dìaz R. Belloso,Pilar Gómez‐Gil ORCID

Live enrichment

PubMed:26657633

National Institutes of Health

Grant: 3U19AG063911-06S4

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

National Institutes of Health

Grant: 1ZIAAG000949-17

Genome wide SNP analysis in Parkinson's disease

National Institutes of Health

Grant: 5U01NS050095-05

Parkinson's Disease Data Organizing Center

National Institutes of Health

Grant: 1ZIANS003154-09

Genetic characterization of atypical parkinsonism

hybridLicense: CC BY NC ND

https://doi.org/10.1002/mds.29960

https://doi.org/10.1101/2023.08.28.23294610

https://pubmed.ncbi.nlm.nih.gov/39132902

https://pubmed.ncbi.nlm.nih.gov/37790572

https://pubmed.ncbi.nlm.nih.gov/39132902/

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

MaleDyskinesia, Drug-InducedParkinson's diseaseDopamineGba1Levodopa: adverse effectsGenetics & genetic processesGenetic Predisposition to Disease: geneticsAntiparkinson Agents: adverse effectsLevodopaAntiparkinson AgentsGénétique & processus génétiquesParkinson Disease: geneticsHuman health sciencesGlucosylceramidase: geneticsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2: geneticsGBA protein, humaninfo:eu-repo/classification/ddc/610Dyskinesia, Drug-Induced: geneticsddc:610articlelevodopa-induced dyskinesiaLRRK2Parkinson DiseaseMiddle AgedLife scienceslevodopa‐induced dyskinesiaNeurologySciences du vivantGlucosylceramidaseFemalePolymorphism, Single Nucleotide: geneticsPublished VersionLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Sciences de la santé humainePolymorphism, Single NucleotideNeurologieHumansGenetic Predisposition to DiseaseLRRK2 protein, humanAgedDopamine: metabolismParkinson Disease: drug therapyParkinson’s diseaseScholarlyArticleGenome-Wide Association Study